Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Code

Showing 1,267 results.

Thumbnail for Efficacy, Safety, and Resistance in Pirtobrutinib-Treated CLL/SLL After Covalent BTK Inhibitor Failure: A Systematic Review of the BRUIN Trial Program

CLL - 963

Efficacy, Safety, and Resistance in Pirtobrutinib-Treated CLL/SLL After Covalent BTK Inhibitor Failure: A Systematic Review of the BRUIN Trial Program

Kolluri Prathyusha

Poster Presenter: Kolluri Prathyusha

Thumbnail for Clinical and Prognostic Impact of CEBPA Mutations in Myelodysplastic Syndromes

MDS - 964

Clinical and Prognostic Impact of CEBPA Mutations in Myelodysplastic Syndromes

Mohamed M. Khamis

Poster Presenter: Mohamed M. Khamis

MM - 966

Safety Profile of Elotuzumab-Based Regimens in Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

FNU Raja

Poster Presenter: FNU Raja

Thumbnail for Cardiovascular, Bleeding, and Mortality Outcomes with Acalabrutinib vs. Zanubrutinib in Chronic Lymphocytic Leukemia: A Real-World Analysis from the Epic Cosmos Federated EHR Network

CLL - 967

Cardiovascular, Bleeding, and Mortality Outcomes with Acalabrutinib vs. Zanubrutinib in Chronic Lymphocytic Leukemia: A Real-World Analysis from the Epic Cosmos Federated EHR Network

Abat Khan

Poster Presenter: Abat Khan

Thumbnail for Residual Excess Mortality During the COVID-19 Era in Multiple Myeloma and Related Plasma Cell Neoplasms: A CDC WONDER Counterfactual Predictive Analysis

MM - 968

Residual Excess Mortality During the COVID-19 Era in Multiple Myeloma and Related Plasma Cell Neoplasms: A CDC WONDER Counterfactual Predictive Analysis

Nanditha Karra

Poster Presenter: Nanditha Karra

Thumbnail for Treatment Response of Dasatanib in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients

CML - 969

Treatment Response of Dasatanib in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients

Baalamurugan K T

Poster Presenter: Baalamurugan K T

Thumbnail for Early Acute Kidney Injury and Mortality in Critically Ill Patients With Multiple Myeloma: A Two-Cohort Study

MM - 970

Early Acute Kidney Injury and Mortality in Critically Ill Patients With Multiple Myeloma: A Two-Cohort Study

Aroog Khaliq

Poster Presenter: Aroog Khaliq

Thumbnail for MRD-Adjusted Therapeutic Index of Menin Inhibitors in NPM1-Mutated and KMT2A-Rearranged Acute Myeloid Leukemia: A Genotype-Stratified Systematic Review and Meta-Analysis

AML - 971

MRD-Adjusted Therapeutic Index of Menin Inhibitors in NPM1-Mutated and KMT2A-Rearranged Acute Myeloid Leukemia: A Genotype-Stratified Systematic Review and Meta-Analysis

Sai Mourya Meda

Poster Presenter: Sai Mourya Meda

Thumbnail for A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept Versus Placebo in Patients With Myelofibrosis (MF) and Anemia on Concurrent Ruxolitinib Therapy: The ELRISE MF Study Design

MPN - 973

A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept Versus Placebo in Patients With Myelofibrosis (MF) and Anemia on Concurrent Ruxolitinib Therapy: The ELRISE MF Study Design

Pankit J Vachhani

Poster Presenter: Pankit J Vachhani

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.